OUR PURPOSE IS SIMPLE:

Patients fighting chronic diseases are often denied access to life-saving treatments.

ICERWatch gives patients a voice to fight back.

What Is ICER?

It's Important for Patients to Know

An organization most patients never heard of is now hard at work determining whether recently approved drugs for serious and often life-threatening diseases should be covered by private health plans and made available to patients. Called the Institute for Clinical and Economic Review (ICER), this Boston-based institute describes itself as “a trustworthy, independent source to help assess how valuable a new drug really is.” Yet, ICER has come under increasing criticism due to the methods it uses to decide the “value” of new medicines, and its ultimate purpose of limiting the use of drugs patients and clinicians need.

Read More About ICER​

Latest Posts

Depression 2019

Patients Rising Now advocates on behalf of patients with life-threatening conditions and chronic diseases for them to have access to vital therapies and services. Access

Read More »

Multiple Sclerosis 2019

Patients Rising Now advocates on behalf of patients with life-threatening conditions and chronic diseases for them to have access to vital therapies and services. Access

Read More »
Close Menu